相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cystathionine-beta-synthase: Molecular Regulation and Pharmacological Inhibition
Karim Zuhra et al.
BIOMOLECULES (2020)
Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine -synthase-deficient homocystinuria
Kenneth N. Maclean et al.
FASEB JOURNAL (2019)
Betaine anhydrous in homocystinuria: results from the RoCH registry
Vassili Valayannopoulos et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy
Tomas Majtan et al.
FASEB JOURNAL (2019)
Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies
Erez M. Bublil et al.
BIOCHIMIE (2019)
Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria
Tomas Majtan et al.
HUMAN MUTATION (2018)
Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria
Tomas Majtan et al.
MOLECULAR THERAPY (2018)
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
Andrew A. M. Morris et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria
Tomas Majtan et al.
FASEB JOURNAL (2017)
Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria
Tomas Majtan et al.
BIOMACROMOLECULES (2017)
Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice
Sapna Gupta et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
Enzyme replacement with PEGylated cystathionine β-synthase ameliorates homocystinuria in murine model
Erez M. Bublil et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey
Robert M. Hoffman
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Altered hepatic sulfur metabolism in cystathionine β-synthase-deficient homocystinuria: regulatory role of taurine on competing cysteine oxidation pathways
Hua Jiang et al.
FASEB JOURNAL (2014)
Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: Decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk
Kenneth N. Maclean et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Cystathionine Beta-Synthase Deficiency Causes Fat Loss in Mice
Sapna Gupta et al.
PLOS ONE (2011)
A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment
Kenneth N. Maclean et al.
MOLECULAR GENETICS AND METABOLISM (2010)
A rationale for cystine supplementation in severe homocystinuria
P. J. Lee et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
The use of betaine in the treatment of elevated homocysteine
Amy Lawson-Yuen et al.
MOLECULAR GENETICS AND METABOLISM (2006)
Cerebral edema associated with betaine treatment in classical homocystinuria
AM Devlin et al.
JOURNAL OF PEDIATRICS (2004)
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine β-synthase (CBS) deficiency
R Yaghmai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
分享论文
